I. Satia (Blackburn, United Kingdom), L. Pérez De Llano (Lugo, Spain), A. Malinovschi (Uppsala, Sweden), J. García Rivero (Mogro (Cantabria), Spain)
Periostin as a marker of Th2-related inflammation in patients with different types of chronic obstructive airway disease
F. Garcia-Cosio Piqueras (Palma de Mallorca, Spain)
|  |
Association between blood eosinophil count and risk of exacerbations in patients with COPD
M. Kerkhof (NORFOLK, United Kingdom)
|  |
Predictors of a decreasing frequency of asthma symptoms. Results from the Disease Management Program (DMP) Bronchial Asthma in the North Rhine region in Germany.
A. Weber (Köln, Germany)
| |
Rhinitis and onset of asthma: a 20-year prospective study of a random population sample
H. Meteran (Copenhagen, Denmark)
| |
Protective effect of salbutamol on peripheral airway constriction induced by sputum induction in asthma patients
L. Demey (BRUXELLES, Belgium)
| |
“App” for uncontrolled moderate-severe asthma patients follow-up
S. Herrero Martin (Pamplona (Navarra), Spain)
| |
Exhaled nitric oxide as predictor of bronchial hyperresponsiveness to methacholine in subjects with respiratory symptoms
S. Pizzimenti (Torino, Italy)
| |
Dynamic hyperinflation: an important target for treatment in asthma
A. van der Meer (Leeuwarden, Netherlands)
| |
Real world evaluation of asthma control risk factors and management: findings from China national asthma control surveys
D. Yang (Shanghai, China)
| |
Lung Clearance Index (LCI) measurements are reproducible and associated with airway physiological changes in steroid naive asthmatic (SNA) adults
J. Rafique (Altrincham, United Kingdom)
| |
Exacerbation utilities and durations by type: estimates from Phase III benralizumab studies
S. Golam (Gothenburg, Sweden)
| |
Breaking the cycle – enhancing asthma care through development of an asthma care bundle
B. Mann (Slough, Berkshire, United Kingdom)
| |
Clinical significance of blood neutrophil differential count in patients with COPD
Y. Hong (Chunchen, Republic of Korea)
| |
Blood EOSinophil counts in asthmatic patients in Italy (EOS study)
A. Rossi (Verona, Vr, Italy)
| |
Evaluation of FeNo measurement as an alternative to sputum eosinophils in a severe asthma population
G. Tavernier (Manchester, United Kingdom)
| |
Exploring the clinical utility of measuring reversibility in mid expiratory flow and its relationship with FEV1 reversibility in patients with asthma.
I. Laska (Prahran, VIC, Australia)
| |
Association between blood eosinophil count and exacerbation risk in patients with asthma receiving medium- or high-dosage inhaled corticosteroids
M. Kerkhof (NORFOLK, United Kingdom)
| |
Systemic and airways oxidative stress in competitive swimmers training in indoor chlorinated swimming pools
S. Skrgat (Golnik, Slovenia)
| |
Clinical impact of vitamin D deficiency on Tunisian asthmatics
F. Yangui (Tunis, Tunisia)
| |
Clinical and spirometric features of asthma patients with fixed airway obstruction
F. Yangui (Tunis, Tunisia)
| |